“COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disruptions to services for HIV, tuberculosis, and malaria in low-income and middle-income countries with high burdens of these diseases could lead to additional loss of life over the next 5 years.”
A civil society discussion paper on key trends and principles for evolution.
“The aim of this paper is to serve as a catalyst for discussion within civil society on how, drawing on lessons from the global HIV response, the global health architecture of the Universal Health Coverage (UHC) era should evolve and how it should be governed so that it best addresses the interests of end-users. The paper celebrates the growing momentum of the Sustainable Development Goals (SDGs) and UHC movements and situates itself within the larger discourse around health, HIV, development, and aid. With a focus on what we call the ‘global health
architecture’, we consider top-line political trends affecting global health and suggest key principles to consider as the architecture adapts to a changing world. “
“Tuberculosis (TB) is the number one killer of people living with HIV/AIDS, causing one in three of all AIDS-related deaths. Yet, unlike HIV, TB is curable: each one of these 250,000 deaths annually is preventable. All people living with HIV should be screened for TB, yet many countries do not report screening for TB in this vulnerable population.”
“To support delivery of antiretroviral therapy (ART) at scale, the World Health Organization (WHO) has promoted a public health approach to HIV treatment and care. Recognizing the
critical importance of streamlined, standardized approaches to scaling up HIV services in settings with limited resources, the public health approach emphasizes strategies such as task
sharing, decentralization and integration of HIV services with other public health programs, and patient and community empowerment. The public health approach also prioritizes
streamlined clinical and laboratory monitoring, standardized first- and second-line treatment regimens, and harmonized monitoring and evaluation strategies [1,2]. In high-income countries with more resources and fewer HIV cases a more individualized approach to HIV care is favored, although the overarching framework of the public health approach provides the setting wit...
The 2019 G-FINDER Report: “[This] project has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development (R&D) of new products to prevent, diagnose, control or cure neglected diseases in developing countries. It provides an up-to-date analysis of how R&D investments are being allocated across diseases and product types, funding trends over time, and where the potential gaps lie. This is the twelfth annual G-FINDER report, providing new data on investments made in financial
year 2018. In all, 262 organisations completed the survey for FY2018, which covered 36 neglected diseases and all relevant product types – drugs, vaccines, biologics, diagnostics, microbicides and vector control products (chemical and biological control agents, and reservoir targeted vaccines) – as well as basic research.”
“This case study looks at the challenges faced in sustaining HIV prevention programmes among KAPs, implemented primarily by civil society organisations (CSO’s), as a result of the withdrawal of the Global Fund through the transition period of 2020 to 2022 and the lack of government capacity and resources to maintain the already limited services that will likely result in the re-emergence of HIV epidemics among people who inject drugs (PWID), sex workers (SW) and men who have sex with men (MSM).”